Biology Conference Alert: Events on drug discovery

Showing posts with label Events on drug discovery. Show all posts

Sunday, August 5, 2012

Metabolic Disease Drug Development - USA (October 2012 )

Expanding epidemic. Unmet medical need. Enormous market potential.

The combination of an escalating metabolic epidemic and limitations of current drugs has created an enormous market opportunity for drug developers.

Today, 34% of US adults have the metabolic syndrome, a constellation of symptoms including obesity, insulin resistance and dyslipidemia. Such figures are leading industry experts to predict that the global market of metabolic drugs will reach$138bn by 2016.

The current excitement generated by the enormous cardiometabolic market potential is tempered by apparent shortcomings in currently available drug classes. New metabolic therapies will have to demonstrate mechanisms of safe and significant glycemic and lipidemic efficacy. Drug developers will also have to understand and mitigate the CV risk associated with the major metabolic diseases in order to navigate the challenging regulatory environment.

We worked closely with senior figures at Merck, Boehringer Ingelheim, Johnson & Johnson, AstraZeneca and many others to construct an agenda which will address these concerns directly. As such, this meeting promises high level, commercially directed discussion of the most pressing technical and strategic issues at hand.

Attend this meeting to:

• Get expert insight from industry clinicians on how best to satisfy regulators and speed drugs to market
• Explore mechanisms of action of the latest T2DM and obesity drug classes to optimize your own drug development
• Uncover new pathways and druggable targets to replenish the obesity and T2DM pharmaceutical pipeline
• Hear from industry experts on how best to mitigate against the CV and systemic risk associated with metabolic drugs
• Increase efficiency by hearing from the leading solution providers
Who should attend this meeting:
• Drug developers focusing on developing novel metabolic drugs
• Scientists and academics working in diabetes, obesity and dyslipidemia
• Clinicians and CROs specializing in metabolic drug trials

More about the Event

Indian Lab Automation Conference and Exhibition

The three topics that will be discussed at this
event are;
* Drug Discovery & Development,
* Advances in Bioanalysis and Advances in Genomics
* Informatics.

For more information

Metabolic Disease Drug Development 2012 - USA

Drug Design 2012 at United Kingdom

DrugDesign 2012 - Oxford’s first structure-based drug design conference - will address the latest developments in computational and experimental approaches to ligand- and structure-based drug design. This conference is aimed at bringing together scientists from academia and industry to stimulate and step up the development of cutting-edge in silico and experimental drug design approaches. The conference invites podium and poster proposals in the following general areas of drug design:-

Molecular modelling and simulation
Novel drugable targets: Identification and selection
Fragment binding and selectivity
Structure-based inhibitor design
Ligand design and identification
Target-ligand interaction (including proteins and nucleic acids)
In silico and experimental screening technologies

Who Should Attend

Academia: Lab heads, postdoctoral researchers, graduate research students
Industry: Team leaders, junior researchers, research managers and decision makers

Further details and to register

International Conference on Central Nervous System - Drugs Effects & Novel Drug Development

OMICS Group invites all the participants across the globe to attend the International Conference on Central Nervous System - Drugs Effects & Novel Drug Development during September 5-7, 2012 at DoubleTree by Hilton Philadelphia, USA.
Central Nervous System-2012 is a remarkable event which brings together all the leading universities, Central Nervous System researchers as well as institutions, making the conference a perfect platform to share experiences, foster collaborations across industry and academia and also evaluate emerging technologies across the globe.
International Conference on Central Nervous System - Drugs Effects, Novel Drug Development will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Research of Central Nervous System across the world. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies.
Conference Highlights the following topics:
• Disorders related to CNS • Behavioral Neurology
• Clinical Neurophysiology • Oncology of Central Nervous System
• Neurodegenerative Diseases • Remedies for CNS & Neurological Disorders
• CNS Biomarkers • Clinical Trials on CNS
• Drug Metabolism in Drug Design and Drug Interactions
• Neurological drug targets CNS & Neurological Disorders

Important Dates
Abstract submission opens on 7th November 2011
Registration opens on 21st November 2011
Abstract submission closes on 5th April 2012
Early bird Registration closes on 10th April 2012
Deadline for Registration 23rd July 2012
On spot Registration 5th September 2012

Welcome to the Official Attendee Housing Site for the International Conference & Exhibition on Central Nervous System, will be Held in the beautiful and exciting city of Philadelphia, USA. The conference will take place in the following dates and locations.
Conference Dates: September 5-7, 2012
Venue:
DoubleTree by Hilton
237 S Broad St, Philadelphia, Pennsylvania 19107, United States
Phone:+1 215-893-1600
Fax: 1-215-893-1663
doubletree1.hilton.com

Further details and to register

4th Annual Drug Development Leaders Summit, Switzerland 2012

Oxford Global Conferences are pleased to announce the 4th Annual Drug Development Leaders Summit being held in June 2012 in Switzerland.

The event offers over 250 attendees a valuable opportunity to network with senior-level decision-makers from leading pharmaceutical, biotech companies, clinical research institutions, academic and healthcare institutions working throughout the Drug Discovery & Development Value Chain.

The Pharmaceutical Industry is facing rising clinical development costs and falling drug discovery success rates. In order to stay competitive, they are re-evaluating their drug development processes and working to reduce late phase attrition rates. The industry is investing more in safety and research measures than ever before and combined with an ever-changing framework of regulation the path the market has never been more complicated or costly for key practitioners in Drug Development. There is an urgent need for improved phase processes, Partnering and Outsourcing strategies and Novel Technologies that will enable the delivery of improved drugs to market quicker and ultimately the establishment of a more robust and lean pipeline.

Do not miss out on our co-located the 13th Drug Discovery Leaders Summit, which provides a first class educational and networking opportunity for attendees to gain knowledge and insights into the entire Drug Discovery marketplace.

Further details and to register

USA 2012: Drug Discovery Technology World Congress

A new paradigm in drug and diagnostic development is emerging. Exciting scientific discoveries in genome biology and technology are paving the way to new product development and commercial opportunities for Rx, Dx and technology platform companies. Join us in San Francisco this August for IBC's all new Drug & Diagnostic Development event - featuring these 4 compelling conferences:

August 06-08, 2012 · The Westin San Francisco Market Street · San Francisco, CA

Further Event Details

Australia 2012: International Microbicides Conference - From Discovery to Delivery

2012 International Microbicides Conference - From Discovery to Delivery

THE FULL CONFERENCE PROGRAM IS AVAILABLE!

"To share in the latest developments in HIV prevention through microbicides and other technologies, this is the conference to attend. The conference is the key event in the microbicides world, where cutting edge research will be presented by world experts, and you will have a chance to interact with people involved at every level of microbicides development "
Professor John Kaldor, The Kirby Institute and Conference Co-Chair

Come to Sydney in April for the 2012 International Microbicides Conference - 'From Discovery to Delivery', with state of the art plenary lectures on microbicides and other aspects of HIV prevention research, cross-disciplinary symposia, oral abstracts, and poster sessions.

M2012 will be a global forum for the presentation and discussion of the latest information on microbicides and oral pre-exposure prophylaxis for HIV prevention and their interface with other prevention strategies. There will be a strong emphasis on the role of community in both research and implementation of scientific findings. The conference is interdisciplinary, and will include basic science, pharmacokinetics, formulation and delivery, clinical research, public health, prevention science, and social and behavioural research.

WHY SHOULD YOU COME?

1. LEARN... From experts from around the world who will speak on key issues in HIV prevention technologies.
2. NETWORK... with a cross-disciplinary group of researchers, community representatives and policy makers, to support you in applying new approaches and perspectives in your work.
3. PARTICIPATE... in sessions that will range from state of the art lectures, to debates on hot topics in microbicides development.

We would like to acknowledge Colin Batrouney for designing the M2012 logo.

Register Now

Switzerland: 4th Annual Drug Development Summit 2012

Over 250 attendees

Over 35 outstanding presentation/panel discussions

4 interactive streams:
• Translational Biomarkers for Safer Drugs
• PK/PD Value and Strategies
• Improving Global Drug Development: Regulation Guidelines, Risk Management and CRO Selection
• Modeling Methods – Early Toxicity Risk Discharge

14 pre-scheduled one to one business meetings & exhibition

Co-located with the 13th Annual Drug Discovery Leaders Summit

Oxford Global Conferences are pleased to announce the 4th Annual Drug Development Leaders Summit being held in June 2012 in Switzerland. The event offers over 250 attendees a valuable opportunity to network with senior-level decision-makers from leading pharmaceutical, biotech companies, clinical research institutions, academic and healthcare institutions working throughout the Drug Discovery & Development Value Chain.

The Pharmaceutical Industry is facing rising clinical development costs and falling drug discovery success rates. In order to stay competitive, they are re-evaluating their drug development processes and working to reduce late phase attrition rates. The industry is investing more in safety and research measures than ever before and combined with an ever-changing framework of regulation the path the market has never been more complicated or costly for key practitioners in Drug Development. There is an urgent need for improved phase processes, Partnering and Outsourcing strategies and Novel Technologies that will enable the delivery of improved drugs to market quicker and ultimately the establishment of a more robust and lean pipeline.

Do not miss out on our co-located the 13th Drug Discovery Leaders Summit, which provides a first class educational and networking opportunity for attendees to gain knowledge and insights into the entire Drug Discovery marketplace.

Further Conference Details

Czech Republic: Natural Anticancer Drugs conference

Natural Anticancer Drugs (NAD2012) will be held from June 30 to July 4, 2012, in Olomouc, Czech Republic. NAD will attempt to inform about the most current topics in natural anticancer drug research, including drug discovery, production of natural compounds, molecular targets and mechanisms, chemoprevention, and successful stories. Invited keynote speakers will give plenary lectures on the hot topics covering a broad range of research areas related to natural compounds. NAD is aimed at the whole scientific community including students, academics, and industry researchers who are interested in the fundamental mechanisms underlying anticancer activity of natural compounds. Further Conference Details

USA: 4th Annual Ubiquitin Drug Discovery & Diagnostics Conference

We will host an exciting cast of emerging and established ubiquitin-focused professionals from the academic, pharmaceutical, biotech and business communities. The three-day conference and workshop is unique in its focus on drug discovery within the ubiquitin pathway; and in its balance of both industrial and academic appeal. Delegates will have the opportunity to network with like-minded researchers from around the world in roundtable discussions, poster sessions and an innovative pre-conference workshop. The workshop, covering topics in assays and assay platforms, substrate identification, and ubiquitylation, will begin the program. The focus will be on technical advances in ubiquitin research and its application to the treatment of human disease. Past Keynote speakers include a Noble Laureate, Distinguished Academic Faculty and C-Suite Executives. The conference program will cover topics in oncology, infectious diseases, neurodegeneration, inflammation, diabetes and muscle wasting.

Conference Details

USA: 2nd Genomic & Proteomic Drug Discovery Conference

With omics based technologies, novel genes and potential candidate proteins can be quickly identified. However, the discovery of viable drug targets still remains a challenge in the genomic and proteomic field while regulatory and ethical issues continue to hinder the process of bringing drugs into the market. Meanwhile, pharmacogenomic studies remain at the forefront for developing personalized medicine.
GTC’s 2nd Genomic & Proteomic Drug Discovery Conference is a 2-day meeting to be held on May 30-31st, at the Hyatt Harborside in Boston, MA. Additionally, there will be a supplementary Clinical Sequencing Workshop to be held on May 29th. The conference will be a forum for the use of omics based methods such as next generation sequencing and mass spectrometry for biomarker discovery and the development of novel therapeutics. Technology, diagnostics and major pharmaceuticals such as Pfizer, Roche, Novartis, GlaxoSmithKline, Merck , Genzyme, Lifetechnologies, Agilent and more will meet with academic and government experts to discuss the novel applications of omics based research and its implications toward personalized medicine.

Conference Website

2012 USA Bioconference - 7th Protein Kinases in Drug Discovery

GTCbio is proud to present our 7th Protein Kinases in Drug Discovery Conference! This meeting will be held May 30-31, 2012 at the Hyatt Harbor Hotel in historical Boston, Massachusetts, one of the most concentrated academic and industrial areas in the United States. We will bring together industry leaders from major pharmaceutical companies, biotech companies as well as top researchers from academia and government to provide you with a better understanding of the complex activities of kinases and some solutions to the challenges associated with kinase drug development. The meeting will offer you an intimate forum to engage in discourse with other distinguished researchers involved in the most cutting-edge kinase work!

Read More about The event

National Symposium on Technology, Health & Environment: An Integrated Approach - India 2012

Sanghvi Institute of Management & Science

Celebrating Science Day

National Symposium on Technology, Health & Environment: An Integrated Approach"

28 & 29 February 2012

Organized by

Department of Biotechnology & Engg. Chemistry
School of Engineering
Sanghvi Institute of Management & Science

About the Symposium

This symposium aims to celebrate the Science Day "28th February" and to create awareness about Technology, Health & Environment.

Symposium Objectives

To provide a special forum for the students and academician to present, discuss and promote the Research in the areas of Biotechnology, Engineering, Environmental Sciences and Chemistry.

Sub Themes

1. Bio-Technology for beHer health.
2. Green Chemistry.
3. Nanotechnology.
4. Engineering for greener environment.
5. Bioinformatics.
6. Biochemistry, Drug Designing and QSAR.
7. Environmental Science .

Registration Details

1. Registration fees
Faculty: 300 Rs.
Student: 200 Rs.

2. On the spot registration

Faculty: 400 Rs.
Student: 300 Rs.

DO or Cheque should be in favour of "Sanghvi Institute of Management & Science"payable at Indore (M.P.).

Important Dates

1. Last Date of Submission of abstract and full paper 18-02-2012
2. Notification of acceptance of abstract and full paper 23-02-2012
3. Last Date of registration 23-02-2012

More Details on The Conference

India 2012 - Workshop On Chemoinformatics and Computational Drug Design, Lucknow

Workshop On
Chemoinformatics and Computational Drug Design
Feburary 27-29, 2012
Organized by
Biotech Park, Lucknow
The Workshop :
Target oriented drug designing has been the main stay in drug discovery. With advances in Biological sciences several new targets have been discovered and designing a target specific drug has been a major challenge. Chemoinformatics and computational drug design has therefore assumed great significance in drug discovery process.
Chemoinformatics and Computational Drug Design approaches are based on the identification and characterization of small molecules targeting a particular biological target. If a validated 3D structure of biological target is not available, it may be possible to design a homology model of the target molecule.
Chemoinformatics based drug designing helps in drug discovery by utilizing structural information to improve the lead optimization. Together chemoinformatics and computation drug design have assisted in virtual screening, lead optimization, fingerprinting, pharmacophore designing, target identification. Molecular modeling using 3D graphics and optimization techniques helps the scientists to understand how drugs bind to proteins in the body.
Classically, protein structure has been exploited in lead optimization, a process that uses structure to guide the chemical modification of a lead molecule to give an optimized fit in terms of shape, hydrogen bonds and other non-covalent interactions with the target. Protein structure can also be used in target identification and selection. These approaches are being increasingly used by research scientists in academic institutions and pharma industries as they help to reduce the time and cost in drug discovery process.
The workshop aims:
I) To familiarize the participants with applications of Bioinformatics in drug discovery.
ii) To familiarize the participants with applications of chemoinformatics and computational biology in drug designing.
iii) To acquaint participants with the current approaches of rational drug designing for specific, and non-toxic small-molecules through guided practicals.
iv) To acquaint participants with in silico chemical and structural fingerprinting, designing and preparation of lead molecules for drug designing and various tools and techniques of Bioinformatics and molecular modeling, docking and dynamics methods.
The participants of the workshop will be accessing online resources of macromolecule libraries, sketching chemical compounds and building 3-D molecules and undertaking molecular docking. They would also learn about prediction and analysis of various properties of compounds, bimolecular and structure prediction and visualization and their interaction analysis. The knowledge gained through this hands on workshop will help them in enhancing their skills in utilizing Bioinformatics tools for their application in basic and industrial research & employment potential in research institutions and industry engaged in drug discovery.
Who should attend : Scientists / Research fellows (National Laboratories, Universities & other R&D institutions) and Graduate / Post graduate students in Engineering / Biological / Chemical sciences/ Medical discipline.

Duration : February 27-29, 2012
Number of Participants : A total of 25 participants will be accepted on first come first serve basis
Registration Fee : Rs 2,000/- per participant. The registration fee includes lectures/presentation handouts, stationary, local transportation, lunch and tea. Fee is to be paid through bank draft drawn in favour of “CEO, Biotech Park, Lucknow”. Completed registration form along with the fee should reach, CEO, Biotech Park on or before February 20, 2012.
Venue :
Biotech Park, Sector-G, Jankipuram, Near Biotech
Square, Kursi Road, Lucknow-226021.
E-mail : sna.biotech@gmail.com,aobiotechpark@gmail.com
www.biotechpark.org.in
Deadline : 20.02.12
View Original Notification

SMi’s Drug Design Conference 2012 - London, United Kingdom

SMi’s Drug Design Conference will aim to address many of the challenging issues faced by the pharmaceutical industry in drug design. Key selected industry experts will provide you with timely and up-to-date information on many areas of drug

The number of pharmaceutical products entering the market has declined in the last decade. With the economic downturn and increasing threat from generic companies, pharmaceutical companies have never been under greater pressure to develop new innovative drugs. Many pharmaceutical and biotechnology companies are now searching for effective strategies to improve hit-to-lead conversion and to identify unsuccessful compounds early in the development process.
SMi’s Drug Design Conference will aim to address many of the challenging issues faced by the pharmaceutical industry in drug design. Key selected industry experts will provide you with timely and up-to-date information on many areas of drug design.

20 to 21 February 2012
London, London, United Kingdom

Conference Details

National Seminar cum Workshop on Drug Design and Industrial Applications

National Seminar cum Workshop on
"Drug Design and Industrial Applications"
March 7-9, 2012
Organized by
Pondicherry University

About the Centre :
Centre for Bioinformatics of Pondicherry University is a national facility funded by the Department of Biotechnology, Department of Information Technology and University Grants Commission. The Centre offers M.Sc. course and Ph.D., in Bioinformatics. The Centre has received Centre of Excellence for Teaching and Research in Bioinformatics by the Department of Information Technology, Govt. of India. Under this programme the centre is offering modular courses in various areas of Bioinformatics for personnel from industry and academia and depending on successful completion of the 4 modules, PG Diploma degree in Bioinformatics is awarded. From 2010, the Centre is offering a M.Sc. Course in Computational Biology with full support from Department of Biotechnology, Govt. of India as a collaborative network programme. The Centre has access to several online and offline e-journals. A modern computational facility is available round-the-clock to all the students of Bioinformatics. The Centre has conducted more than 35 Seminars/ Workshops during the past years.
About the Seminar :
The 3-day National level Seminar cum Workshop sponsored by Department of Biotechnology (DBT), India will focus on "Drug Design and industrial applications", which involves diversified topics in bioinformatics. Experts in various fields will deliver lectures and conduct demonstrations followed by hands-on training. The seminar will be very useful to the faculty and students interested in drug designing and its extension to pre-clinical studies, which are of immense scope in pharmaceutical industries.
Sponsors :
a. Department of Biotechnology (Ministry of Science & Technology, Government of India)
b. Pondicherry University
Topics :

Transcriptomics and protein chemistry
Rational drug design for severe diseases
Evaluating drug solubility in lipid-based delivery system
Micro and Nano Drug encapsulation
Biosimilar Medicines - Understanding the challenges
Computerized Cognitive function Assessment
Preclinical Research- Vertical Integration
Policy and projections towards business Development

Registration Fee for Participants :
1. Student - Rs. 1500/-
2. Faculty / Staff - Rs. 2000/-
3. Industry - Rs. 2500/-

The registration fee includes seminar material and working lunch on all the days of the seminar.
Total number of participants : 30 (Participation will be confirmed on first come first served basis)
Accommodation for the participants : Limited number (on payment basics may be arranged on advance request)

Interested candidates need to take Demand Draft in favour of The Centre Head, Bioinformatics Seminar, Pondicherry University, Pondicherry
Registration closes on : February 29, 2012
View Original Notification

National Conference on Biomarkers for Diseases – Prospects & Challenges

National Conference on

Biomarkers for Diseases – Prospects & Challenges

24th & 25th February 2012

Organized By

Centre for Biotechnology and Bioinformatics (CBB)
School of Life Sciences (SLS),
Jawaharlal Nehru Institute of Advanced Studies (JNIAS)
Hyderabad

Conference Objectives:

 The goals of this Conference are to assess the existing biomarkers available and explore the kinds of biomarkers needed to provide improvements to the human condition by alleviating disease and extending healthy lifespan.
 The National Conference will provide a forum for an interactive transfer of current ideas and information.
 The two day Conference aims to bring together researchers, professionals and students, working in the molecular biology area and active in a wide range of studies on biomarker concept and disciplines.
 This Conference is designed to update Scientists and Clinicians on recent research related to the integration of biomarkers in the clinical treatment of diseases, thereby enhancing patient outcome.

Conference sub themes:

 Integrated biomarkers of various diseases
 Biomarkers for diseases prediction and Model biomarkers
 Biomarkers in clinical practice and Disease progression
 Biomarkers in newer areas like Metabolomics and Genomics
 Future trends in biomarkers for Research and Development Call for Papers / Posters and Guidelines to Authors:
 The Conference has Oral and Poster Presentations.
 The soft copy of the abstract of the Research Paper / Poster not exceeding 300 words on various themes of the Conference (A4 size, MS word, Arial font-12, Line spacing 1.5 pt) should be e-mailed to ncbm.jnias@gmail.com.

Selected abstracts shall be confirmed by e-mail.

Important Dates:

1. Last date for submission of abstracts - January 25, 2012
2. Last date for submission of Full Paper - February 10, 2012
3. Last date for Registration - February 20, 2012

Registration Fee:

1. Delegates from Industries: Rs 1000/-
2. Faculty from Universities & Colleges: Rs. 500/-
3. Students: Rs. 250/-

Conference Website: www.jnias.in/ncbm/index.php

National Workshop On Molecular Modeling for Drug Designing

National Workshop On Molecular Modeling for Drug Designing

March 13th -17th, 2012

Under

Bioinformatics Infrastructure Facility of
Department of Biotechnology, New Delhi
&
Special Interest Group on Bioinformatics of
Computer Society of India

Organized by

Department of Applied Mathematics & Humanities
Sardar Vallabhbhai National Institute of Technology, Surat

Topics/Contents to be Covered
 System biology and its role in Drug Designing
 Molecule structure representation and visualization
 Structure databases: PDB, CATH, SCOP, FSSP, PubChem
 Molecule Drawing tools: Chemsketch and JDraw
 Structure optimization: Molecular mechanics and dynamics. Force field
 Computational methods in protein folding study
 Protein structure prediction: Homology modeling and threading
 Computational methods in Molecular docking: Protein-protein, drug-protein, DNA-Protein
 Methods in drug designing
 QSAR study
 Case studies.
MMDD Brochure

India - National seminar on "Computer Aided Drug Design"

3rd National Seminar On
Computer Aided Drug Design
29th - 30th December, 2011
Supported by DBT, Govt Of India

CALL FOR POSTER PRESENTATION :
We extend our cordial invitation to attend DBT sponsored 3rd National seminar on COMPUTER AIDED DRUG DESIGN to be organized by SVIMS Bioinformatics Centre, SVIMS University, Tirupati from 29-30th December 2011. The main objective of the National conference is to bring together scientists, researchers, students from academia and corporate companies to share their informatics research experiences in the field of molecular modeling and drug design. Moreover, the participants will get opportunities to enlighten their bioinformatics skills to implement in their respective research field. Researchers will also be encouraged to present their research works.
Eligibility : Faculty, Students, Research Scholars working in the area of Bioinformatics, Biotechnology, Computational Biology, Microbiology, Biochemistry and various other branches of Life Sciences are invited to attend the workshop.
Registration Fee : Rs. 500/- for students Rs. 800/- for staffs. ; The registration fee includes Seminar Kit, working lunch and tea for two days of the Workshop. Participants are requested to send the registration form available in this brochure. Participants can also register online at http://svimsbic.org/register.html . The registration fee should be paid by cash or in the form of crossed Demand Draft drawn in favor of the organizing secretary, National Seminar on Computer aided Drug Design, BIF, SVIMS University, Tirupati, on or before 20th December, 2011. Registration form can also be photocopied.Venue : SVIMS Auditorium & SVIMS Bioinformatics Centre
For any queries regarding seminar, please feel free to contact
Dr. A. Umamaheswari
Organizing Secretary, National Seminar on COMPUTER AIDED DRUG DESIGN
SVIMS University, Tirupati
Email: svims.btisnet@nic.in
Phone: +91-0877-2287727
Deadline : 20.12.11
View Original Notification

Pages

Share It

Top Menu

Sunday, August 5, 2012

Monday, July 23, 2012

Wednesday, June 13, 2012

Sunday, June 10, 2012

Thursday, May 3, 2012

Wednesday, April 4, 2012

Wednesday, March 28, 2012

Friday, March 23, 2012

Tuesday, March 6, 2012

Sunday, February 12, 2012

Sunday, February 5, 2012

Wednesday, January 18, 2012

Saturday, January 14, 2012

Tuesday, January 10, 2012

Monday, December 19, 2011

Thursday, December 15, 2011

Most Visited Event